| Literature DB >> 26702298 |
Shasha Zhang1,2, Xuejin Zhao1, Yong Tao1, Chunbo Lou1.
Abstract
BACKGROUND: Imbalances in gene expression of a metabolic pathway can result in less-yield of the desired products. Several targets were intensively investigated to balance the gene expression, such as promoter, ribosome binding site (RBS), the order of genes, as well as the species of the enzymes. However, the capability of simultaneous manipulation of multiple targets still needs to be explored.Entities:
Keywords: Gene order; Lycopene; Oligo-linker mediated DNA assembly; Pathway optimization; RBS; Species of enzymes
Year: 2015 PMID: 26702298 PMCID: PMC4688952 DOI: 10.1186/s13036-015-0021-0
Source DB: PubMed Journal: J Biol Eng ISSN: 1754-1611 Impact factor: 4.355
Fig. 1Schematic overview of the oligonucleotides-linkers-mediated DNA assembly (OLMA) method. During the assembly process, each large fragment was cloned into a standard Donor vector, while double-stranded oligonucleotides as linker were obtained by annealing two complementary ssDNA and generating two proper overhangs (e.g. 0-R and 1-L as left and right overhangs of the first oligo respectively). The large fragments and the receptor vector were bridged by the overhangs of the Oligo-linkers in a single Golden-Gate assembly reaction
Construction efficiency of the assembly of LacZ gene using OLMA method
| Plasmids | Number of pieces to assemble | Total colonies(cfu/ug input DNA) | Positive rate (%) |
|---|---|---|---|
| lacZ | 1 | 104 | 99.9 |
| Z1 + Z2 + Z3 | 3 | 103 | 95.0 |
| Z1 + Z2 + Z3 + Z4 | 4 | 500 | 43.0 |
| Z1 + Z2 + Z3 + Z4 + Z5 | 5 | 10 | 10.0 |
Fig. 2Optimization of lycopene synthetic pathway using OLMA. a The metabolic pathway from IPP&DMAPP to lycopene in E. coli. (b) OLMA was used to optimize RBS, coding sequence and gene order to fine-tune lycopene synthetic pathway
Fig. 3The results of individual modulation of the RBSs, coding sequences and gene order by OLMA. a RBS library was constructed using the OLMA method. 10–20 RBSs were chosen for each gene of PanEBI with crtE-I-B order. (b) Coding sequence library was constructed by the OLMA method. CrtEBI from 4 species were assembled as crtE-I-B order with the medium strength RBSs E9_6689, B1_5557, I3_3088 and id1_10974. (c) Gene order library was constructed using the OLMA method. The PanE, PanB and PanI genes were assembled in all six orders. The dynamic range and c-factor of each library were shown in the figures
Oligos synthesized for the optimization of lycopene synthestic pathway. Oligos with 3 different overhangs was synthesized for 3 different assembly orders
| Oligo | Sequence | Oligo | Sequence |
|---|---|---|---|
| Reverse design | Forward design | ||
| E4_17864-R | CCGT | CrtE_13822 R | CCGT |
| E4_17864-F | GTATtgttcaattaatgaggaaattgta | CrtE_13822 F | GTATatggtaaaaagaaaggagagtgaat |
| B-E4_17864-F | GGCCtgttcaattaatgaggaaattgta | B-CrtE_13822 F | GGCCatggtaaaaagaaaggagagtgaat |
| I-E4_17864-F | TTAAtgttcaattaatgaggaaattgta | I-CrtE_13822 F | TTAAatggtaaaaagaaaggagagtgaat |
| B13_51518-R | TATT | CrtB_12823 R: | TATT |
| B13_51518-F | GTATaaaaggaaaggaggaaagaaata | CrtB_12823 F | GTATtctagagaaagaggagaaatactag |
| E-B13_51518-F | CAGGaaaaggaaaggaggaaagaaata | E-CrtB_12823 F | CAGGtctagagaaagaggagaaatactag |
| I-B13_51518-F | TTAAaaaaggaaaggaggaaagaaata | I-CrtB_12823 F | TTAAtctagagaaagaggagaaatactag |
| I15_28086-R | GTTT | CrtI_18732 R: | GTTT |
| I15_28086-F | GTATttttgctgaaaggaggaactat | CrtI_18732 F: | GTATgaattcattaaagaggaggaattct |
| E-I15_28086-F | CAGGttttgctgaaaggaggaactat | E-CrtI_18732 F: | CAGGgaattcattaaagaggaggaattct |
| B-I15_28086-F | GGCCttttgctgaaaggaggaactat | B-CrtI_18732 F: | GGCCgaattcattaaagaggaggaattct |
| id16_135699-R | TTTG | idi_14921 R: | TTTG |
| E-id16_135699-F | CAGGgctacataaggaggccctaa | E-idi_14921 F: | CAGGaaaagatcttttaagaagaggagtaaaat |
| B-id16_135699-F | GGCCgctacataaggaggccctaa | B-idi_14921 F: | GGCCaaaagatcttttaagaagaggagtaaaat |
| I-id16_135699-F | TTAAgctacataaggaggccctaa | I-idi_14921 F: | TTAAaaaagatcttttaagaagaggagtaaaat |
Fig. 4OLMA was applied to modulate multiple types of targets in a single assembly step. a A combinatorial library of two types of targets (RBS and gene order), was constructed by the OLMA method. The coding sequences here were PanE, PanB and PanI. (b) A combinatorial library of four RBSs and three coding sequences was constructed using the OLMA method. The gene order here was crtE-I-B. (c) A combinatorial library for varying four RBSs, three coding sequences and the gene order was constructed by the OLMA method. The dynamic range and coverage of lycopene yield were shown in the figures
Details of the top10 lycopene reporter
| Name | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Yield |
|---|---|---|---|---|---|---|---|---|---|
| Order | RBS for crtE | RBS for crtI | RBS for crtB | RBS for idi | crtE | crtI | crtB | ||
| pLY116 | BIE | E3_(1813) | I6_(1137) | B8_(2059) | id12_(3867) | PanE | PanI | PanB | 15.17 |
| pLY111 | BEI | E13_(13670) | I6_(1137) | B1_(5557) | id16_(135699) | PanE | PanI | PanB | 14.69 |
| pLY108 | EBI | E9_(6689) | I4_(1630) | B13_(51518) | id3_(5078) | PvaE | PanI | PanB | 13.86 |
| pLY101 | BEI | E3-(1813) | I10_(3562) | B2_(1147) | id15_(115818) | RspE | PanI | PanB | 12.81 |
| pLY106 | EBI | E9_(6689) | I10_(3562) | B2_(1147) | id6_(4010) | PvaE | PanI | PanB | 12.53 |
| pLY112 | BEI | E16_(13174) | I6_(1137) | B11_(25607) | id14_(31121) | PvaE | PanI | RspB | 12.39 |
| pLY107 | EBI | E9_(6689) | I6_(1137) | B14_(46327) | id15_(115818) | PvaE | PagI | PanB | 12.07 |
| pLY103 | BIE | E14_(5844) | I15_(28086) | B8_(2059) | id14_(31121) | RspE | PanI | PanB | 11.69 |
| pLY109 | EIB | E3_(1813) | I6_(1137) | B4_(3088) | id1_(10974) | PanE | PanI | RspB | 11.33 |
| pLY102 | BEI | E2_(2472) | I11_(340) | B8_(2059) | id12_(3867) | RspE | PanI | PanB | 11.29 |
| Control | EIB | (17707) | (10318) | (10793) | (31786) | PanE | PanI | PanB | 5.54 |
*The numbers with in the parenthese are the theoretical strength of each gene acquired by RBS calculator. The RBS sequences of crtEBI and idi of the Control strain are all “aaggagatata”
Strains and plasmids used in this study
| Strain/plasmid | Description | Reference |
|---|---|---|
| Strains | ||
| Trans5α | F−φ80d | TransGen Biotech |
| DB 3.1 | F−
| Life technology |
| PXIDF | BW25113, △pgi, pT5-dxs, pT5-idi, pT5-ispDF | Our lab |
| Plasmid | ||
| pHD-lacZ1 |
| This study |
| pHD-lacZ3.1 | Partial | This study |
| pHD-lacZ3.2 | Partial | This study |
| pHD-lacZ3.3 | Partial | This study |
| pHD-lacZ4.1 | Partial | This study |
| pHD-lacZ4.2 | Partial | This study |
| pHD-lacZ4.3 | Partial | This study |
| pHD-lacZ4.4 | Partial | This study |
| pHD-lacZ5.1 | Partial | This study |
| pHD-lacZ5.2 | Partial | This study |
| pHD-lacZ5.3 | Partial | This study |
| pHD-lacZ5.4 | Partial | This study |
| pHD-lacZ5.5 | Partial | This study |
| pFUS | pUC origin, Spe R, ccdB operon, | This study |
| pHD-PanE |
| This study |
| pHD-PagE |
| This study |
| pHD-PvaE |
| This study |
| pHD-RspE |
| This study |
| pHD-PanB |
| This study |
| pHD-PagB |
| This study |
| pHD-PvaB |
| This study |
| pHD-RspB |
| This study |
| pHD-PanI |
| This study |
| pHD-PagI |
| This study |
| pHD-PvaI |
| This study |
| pYC1k-ccdB-idi | p15A origin, Tac promoter, KanR, ccdB operon, | This study |
| pSB1s-X | pSC101 origin, Pbad promoter, StrR, | Our lab |
Oligos synthesized for lacZ assembly
| Oligo | Sequence |
|---|---|
| oligo1-1 F | CTATaagcatcagacagcactg |
| oligo1-1R | GTAAcagtgctgtctgatgctt |
| Oligo1-2 F | TTGAagcttatcggatcgagcc |
| Oligo1-2R | CGCCggctcgatccgataagct |
| Oligo3-1 F | CTGAacggcaagc cgttgctga |
| Oligo3-1R | CGAAtcagcaacggcttgccgt |
| Oligo3-2 F | GGATttttgcatc gagctgggt |
| Oligo3-2R | TATTAcccagctcgatgcaaaa |
| Oligo4-1 F | TGACtacctacgg gtaacagtt |
| Oligo4-1R | AAGAaactgttacccgtaggta |
| Oligo4-2 F | GTTTacagggcgg cttcgtctg |
| Oligo4-2R | GTCCcagacgaagccgccctgt |
| Oligo4-3 F | GATTggcctgaac tgccagctg |
| Oligo4-3R | GCGCcagctggcagttcaggcc |
| Oligo5-1 F | TTGGagtgacggcagttatctg |
| Oligo5-1R | CTTCcagataactgccgtcact |
| Oligo5-2 F | GAGCgaacgcgta acgcgaatg |
| Oligo5-2R | GCACcattcgcgttacgcgttc |
| Oligo5-3 F | CTGAactaccgca gccggagag |
| Oligo5-3R | GGCGctctccggctgcggtagt |
| Oligo5-4 F | CGCGcgaattgaa ttatggccc |
| Oligo5-4R | GTGTgggccataattcaattcg |